Singapore markets open in 5 hours 42 minutes
Straits Times Index
3,338.94 -9.93 (-0.30%) S&P 500
5,283.85 +0.45 (+0.01%) Dow
38,660.73 +89.70 (+0.23%) Nasdaq
16,830.28 +1.61 (+0.01%) Bitcoin USD
70,595.54 +1,497.35 (+2.17%) CMC Crypto 200
1,474.73 +27.58 (+1.90%)
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
| Previous close | 32.04 |
| Open | 32.81 |
| Bid | 33.24 x 0 |
| Ask | 33.25 x 0 |
| Day's range | 31.99 - 33.46 |
| 52-week range | 21.60 - 35.49 |
| Volume | |
| Avg. volume | 16,140,466 |
| Market cap | 53.205B |
| Beta (5Y monthly) | 0.04 |
| PE ratio (TTM) | 19.20 |
| EPS (TTM) | 1.73 |
| Earnings date | N/A |
| Forward dividend & yield | 0.80 (2.50%) |
| Ex-dividend date | 29 May 2024 |
| 1y target est | 41.38 |
- Reuters
Merck discontinues some cancer drug development with China's Sichuan Kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials. Representatives for Merck did not immediately respond to a Reuters request for comment. The move comes days after Merck said it would pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs in a deal that could be worth up to $22 billion for the Japanese firm.
© 2024 Yahoo. All rights reserved.